Gestational diabetes & diabetes in pregnancy
Effectiveness of Telemedicine in Managing Diabetes in Pregnancy: A Systematic Review and Meta-Analysis
Authors' conclusion
No evidence was found to support telemedicine as an alternative to usual care when considering maternal and fetal outcomes. However, further research is needed, including economic evaluations.
Study context
- Population
- Pregnant women with gestational or pregestational diabetes; randomized trials searched up to October 14, 202010 of 18 studies
- Participants
- 899 women
- Comparison
- Telemedicine vs any comparator without telemedicine for diabetes in pregnancy
- Outcome
- Infant birth weight
Methodological detailssubgroup and sensitivity analyses, revised Cochrane risk-of-bias tool, Grading of Recommendations, Assessment, Development, and Evaluation (GRADE)
- Subgroup and sensitivity analyses
- Revised Cochrane risk-of-bias tool
- GRADE
Pooled result
As reported in the abstract
MD
19.34 g
95% CI −47.8 to 86.47
Between Telemedicine and Control
MD 19.34 g (95% CI −47.8 to 86.47)
- Heterogeneity (I2)
- 37.39%
Further pooled results
| Outcome | SMD (mg/dL) (95% CI) | |
|---|---|---|
| Two-hour glucose tolerance postpartum (GDM)Favored the control; GRADE very low | 9.62 (1.95–17.28) | |
| −1001020Difference, mg/dL (linear scale) |
| Outcome | Log odds (95% CI) |
|---|---|
| Shoulder dystociaFavored telemedicine; GRADE low | −1.34 (−2.61 to −0.08) |
- Two-hour glucose tolerance postpartum (GDM): 2 studies
- Shoulder dystocia: 4 studies
Original publication
Effectiveness of Telemedicine in Managing Diabetes in Pregnancy: A Systematic Review and Meta-Analysis. J Diabetes Sci Technol. Published 9 May 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →